Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.66 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.64 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.64 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.62 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.62 |
| ▸ | NPY2R | P49146 | 8/20 | 0.60 |
| ▸ | NPY4R | P50391 | 8/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.60 |
| ▸ | NPY1R | P25929 | 6/20 | 0.60 |
| ▸ | F2 | P00734 | 4/20 | 0.60 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30824284 | 0.91 | CALCR (0.64) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL29649209 | 0.91 | CALCR (0.67) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL31182495 | 0.91 | NPY2R (0.70) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL30176423 | 0.90 | CALCR (0.68) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL31182699 | 0.90 | CALCR (0.70) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL31295724 | 0.89 | CALCR (0.66) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL29461421 | 0.89 | CALCR (0.62) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL30824289 | 0.89 | CALCR (0.63) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL30712965 | 0.89 | CALCR (0.71) | CALCRCRHR1CRHR2HCRTR1HCRTR2 | |
| SCHEMBL30432045 | 0.89 | CALCR (0.65) | CALCRCRHR1CRHR2HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248816-A9 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-08-10 | — | — | US | disclosed |
| US-20230066762-A1 | IMMUNOGENIC COMPOSITION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-03-02 | — | — | US | disclosed |
| US-20220288190-A1 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220288190-A1 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | CFD, PEPD, SERPINA6 | CALCR 415/4885CRHR1 1654/4885CRHR2 1690/4885 |
| US-20230248816-A9 | PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE | CFD, PEPD, SERPINA6 | CALCR 415/4885CRHR1 1654/4885CRHR2 1690/4885 |
| US-20230066762-A1 | IMMUNOGENIC COMPOSITION | CXCL10, CCL2, CCL11 | CALCR 1308/4885CRHR1 1576/4885CRHR2 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.